Latest filing published 17 Nov 2021 for Abbott Laboratories, €1.1M.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Andrew H. Lane: trading record in brief
All filings by Andrew H. Lane on record concern Abbott Laboratories, in the capacity of senior executive. Over a trading history stretching from 20 February 2016 to 15 November 2021, the count stands at 41 filings.
Sales make up the whole of the open-market record (9 sales, €28.2M). Besides market trades, the filings include 28 share grants and 4 option exercises. In 2021 alone, the filings show no purchases and 2 sales.
The latest filing, published on 17 November 2021, reports an open-market sale of €1.1M in Abbott Laboratories. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Andrew H. Lane
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$130.00920.4% of flowCommon shares without par valueSEC:0001415889-21-005272:0
- 135,925 shares@ US$38.4079.6% of flowCommon shares without par valueSEC:0001415889-21-004154:0
2 of 2 declarations
